JPRN-jRCT2080221363未知2 期
A Phase 2b study of M512101 in acne vulgaris for 12weeks
适应症
试验速览
- 阶段
- 2 期
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 13age old 至 <= 49age old（—）
- 性别
- All
入选标准
- •1. Patients diagnosed with acne vulgaris
- •2. Outpatient
排除标准
- 未提供
研究者
相似试验
未知
3 期
A phase II/III study of M605101 in acne vulgaris patientsAcne vulgarisJPRN-jRCT2080221742Maruho Co.,Ltd.
未知
2 期
A phase 2b study of M108101 in acne vulgaris patientsAcne vulgarisJPRN-jRCT2080221392Maruho Co.,Ltd.
未知
3 期
A phase III long term study of M605101 in acne vulgaris patientsAcne vulgarisJPRN-jRCT2080221864Maruho Co.,Ltd.
进行中（未招募）
1 期
ot applicableAcne vulgarisMedDRA version: 19.0Level: LLTClassification code 10000519Term: Acne vulgarisSystem Organ Class: 100000004858EUCTR2016-000063-16-DEGalderma R&D SNC60
已完成
2 期
Phase 2, 'Proof of Principle', Placebo Controlled, Randomised, Parallel Group Pilot Study of the Effect of a New Combined Acne Treatment in Patients with Mild to Moderate Acne.Mild to Moderate Acne vulgarisSkin - Dermatological conditionsACTRN12607000140459ifeSource Group Holdings Pty Ltd20